These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Developing combination of artesunate with paclitaxel loaded into poly-d,l-lactic-co-glycolic acid nanoparticle for systemic delivery to exhibit synergic chemotherapeutic response. Tran BN; Nguyen HT; Kim JO; Yong CS; Nguyen CN Drug Dev Ind Pharm; 2017 Dec; 43(12):1952-1962. PubMed ID: 28724314 [TBL] [Abstract][Full Text] [Related]
3. Enhancing the in vitro anti-cancer efficacy of artesunate by loading into poly-D,L-lactide-co-glycolide (PLGA) nanoparticles. Nguyen HT; Tran TH; Kim JO; Yong CS; Nguyen CN Arch Pharm Res; 2015; 38(5):716-24. PubMed ID: 24968925 [TBL] [Abstract][Full Text] [Related]
4. Curcumin-Artesunate Based Polymeric Nanoparticle; Antiplasmodial and Toxicological Evaluation in Murine Model. Oyeyemi O; Morenkeji O; Afolayan F; Dauda K; Busari Z; Meena J; Panda A Front Pharmacol; 2018; 9():562. PubMed ID: 29899700 [TBL] [Abstract][Full Text] [Related]
5. Development of electrosprayed artesunate-loaded core-shell nanoparticles. Ho HN; Laidmäe I; Kogermann K; Lust A; Meos A; Nguyen CN; Heinämäki J Drug Dev Ind Pharm; 2017 Jul; 43(7):1134-1142. PubMed ID: 28277847 [TBL] [Abstract][Full Text] [Related]
6. Antiplasmodial Activity and Toxicological Assessment of Curcumin PLGA-Encapsulated Nanoparticles. Busari ZA; Dauda KA; Morenikeji OA; Afolayan F; Oyeyemi OT; Meena J; Sahu D; Panda AK Front Pharmacol; 2017; 8():622. PubMed ID: 28932197 [TBL] [Abstract][Full Text] [Related]
7. Development of bicalutamide-loaded PLGA nanoparticles: preparation, characterization and in-vitro evaluation for the treatment of prostate cancer. Ray S; Ghosh Ray S; Mandal S Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):944-954. PubMed ID: 27327352 [TBL] [Abstract][Full Text] [Related]
8. Formulation and evaluation of tacrolimus-loaded galactosylated Poly(lactic-co-glycolic acid) nanoparticles for liver targeting. Mistry NP; Desai JL; Thakkar HP J Pharm Pharmacol; 2015 Oct; 67(10):1337-48. PubMed ID: 25944126 [TBL] [Abstract][Full Text] [Related]
9. Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA. Nair K L; Jagadeeshan S; Nair SA; Kumar GS Int J Nanomedicine; 2011; 6():1685-97. PubMed ID: 21980233 [TBL] [Abstract][Full Text] [Related]
10. Hyaluronic acid-decorated poly(lactic-co-glycolic acid) nanoparticles for combined delivery of docetaxel and tanespimycin. Pradhan R; Ramasamy T; Choi JY; Kim JH; Poudel BK; Tak JW; Nukolova N; Choi HG; Yong CS; Kim JO Carbohydr Polym; 2015 Jun; 123():313-23. PubMed ID: 25843864 [TBL] [Abstract][Full Text] [Related]
11. In vitro release characteristics and cellular uptake of poly(D,L-lactic-co-glycolic acid) nanoparticles for topical delivery of antisense oligodeoxynucleotides. Chen YS; Alany RG; Young SA; Green CR; Rupenthal ID Drug Deliv; 2011; 18(7):493-501. PubMed ID: 21696294 [TBL] [Abstract][Full Text] [Related]
12. Preferential hepatic uptake of paclitaxel-loaded poly-(d-l-lactide-co-glycolide) nanoparticles - A possibility for hepatic drug targeting: Pharmacokinetics and biodistribution. Mandal D; Shaw TK; Dey G; Pal MM; Mukherjee B; Bandyopadhyay AK; Mandal M Int J Biol Macromol; 2018 Jun; 112():818-830. PubMed ID: 29421493 [TBL] [Abstract][Full Text] [Related]
13. Targeted and controlled drug delivery system loading artersunate for effective chemotherapy on CD44 overexpressing cancer cells. Tran TH; Nguyen TD; Van Nguyen H; Nguyen HT; Kim JO; Yong CS; Nguyen CN Arch Pharm Res; 2016 May; 39(5):687-94. PubMed ID: 27015824 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin. Guo M; Rong WT; Hou J; Wang DF; Lu Y; Wang Y; Yu SQ; Xu Q Nanotechnology; 2013 Jun; 24(24):245101. PubMed ID: 23702815 [TBL] [Abstract][Full Text] [Related]
15. Poly aspartic acid peptide-linked PLGA based nanoscale particles: potential for bone-targeting drug delivery applications. Jiang T; Yu X; Carbone EJ; Nelson C; Kan HM; Lo KW Int J Pharm; 2014 Nov; 475(1-2):547-57. PubMed ID: 25194353 [TBL] [Abstract][Full Text] [Related]
16. Formulation development and evaluation of the anti-malaria properties of sustained release artesunate-loaded solid lipid microparticles based on phytolipids. Chinaeke EE; Chime SA; Onyishi VI; Attama AA; Okore VC Drug Deliv; 2015; 22(5):652-65. PubMed ID: 24479677 [TBL] [Abstract][Full Text] [Related]
17. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method. Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287 [TBL] [Abstract][Full Text] [Related]
18. Cell Line and Augument Cellular Uptake Study of Statistically Optimized Sustained Release Capecitabine Loaded Eudragit S100/PLGA(poly(lacticco- glycolic acid)) Nanoparticles for Colon Targeting. Pandey S; Vijayendra Swamy SM; Ubaid Ulla UM; Gupta A; Patel H; Yadav JS Curr Drug Deliv; 2017 Sep; 14(6):887-899. PubMed ID: 27538461 [TBL] [Abstract][Full Text] [Related]
19. Tetracycline-grafted PLGA nanoparticles as bone-targeting drug delivery system. Wang H; Liu J; Tao S; Chai G; Wang J; Hu FQ; Yuan H Int J Nanomedicine; 2015; 10():5671-85. PubMed ID: 26388691 [TBL] [Abstract][Full Text] [Related]
20. Preparation, evaluation, and Pan X; Liu S; Ju L; Xi J; He R; Zhao Y; Zhuang R; Huang J Drug Dev Ind Pharm; 2020 Nov; 46(11):1889-1897. PubMed ID: 32975456 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]